GLP-1 drugs like semaglutide, the generic name for Ozempic, go beyond treating diabetes and weight loss to potentially reduce the risk of kidney and cardiovascular diseases, treat liver diseases and neurological disorders, and curb inflammation causing chronic illnesses.
Dr. Daniel Drucker notes GLP-1 drugs present multiple avenues for therapeutic use beyond their original purposes, with ongoing research exploring six to ten different indications for potential medical applications.
[
Collection
]
[
|
...
]